10-Q/A: Quarterly report pursuant to Section 13 or 15(d)
Published on October 27, 2008
听
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
听
FORM
10-Q/A
Amendment
No. 1
(Mark
One)
听
x听QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF
听
THE
SECURITIES EXCHANGE ACT OF 1934
听
For
the
quarterly period ended June听30, 2007.
听
OR
听
o听TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
听
For
the
transition period from ________ to ________.
听
Commission
file number 000-27748
听
小猪视频app
Health, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
|
听
|
听
|
听
|
|
Delaware
|
听
|
75-2402409
|
|
听
|
听
|
听
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
听
|
(I.R.S.
Employer Identification No.)
|
听
4400
Biscayne Blvd., Suite听1180
Miami,
FL
33137
(Address
of Principal Executive Offices)
听
(305)听575-4138
(Registrant鈥檚
Telephone Number, Including Area Code)
听
Indicate
by check mark whether the registrant (1)听has filed all reports required to
be filed by Section听13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12听months (or for such shorter period that the
registrant was required to file such reports), and (2)听has been subject to
such filing requirements for the past 90听days. YES o听听
NO x
听
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a nonaccelerated filer (as defined in Rule听12b-2 of
the Exchange Act). Check one:
| 听 | 听 | 听 | 听 | 听 |
|
Large
accelerated filer o
|
听
|
Accelerated
filer o
|
听
|
Nonaccelerated
filer x
|
听
Indicate
by check mark whether the registrant is a shell company (as defined in
Rule听12b-2 of the Exchange Act):
YES
o听
NO
x
听
1
听
EXPLANATORY
NOTE
听
小猪视频app
Health, Inc. (鈥渢he Company鈥�) is filing this Amendment No. 1 on Form 10-Q/A for
purposes of removing Exhibit 99.1 Financial Statements of Ophthalmic
Technologies, Inc., from its previously filed Quarterly Report on Form 10-Q
filed with the Securities and Exchange Commission on August 13, 2007. In the
Company's 8-K/A to be听filed on听October 24, 2008, the Company听will
file听restated financial statements of Ophthalmic Technologies, Inc. along
with pro forma financial statements听relating to听its equity investment
in Ophthalmic Technologies, Inc.
听
This
Amendment No. 1, together with the Quarterly Report on Form 10-Q of the Company
previously filed for the quarter ended June 30, 2007, constitutes the Quarterly
Report on Form 10-Q of the Company for the quarter ended June 30,
2007.
听
听
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
caused this Report on Form 10-Q/A to be signed on its behalf by the undersigned
thereunto duly authorized.
听
|
Date:听October
24, 2008
|
小猪视频app
Health, Inc.
|
|||
| 听 | 听 | |||
| 听 | 听 | |||
|
听
|
听
|
/s/听Adam
Logal
|
||
|
听
|
听
|
Adam
Logal
|
||
|
听
|
听
|
Executive
Director of Finance, Chief Accounting Officer and
Treasurer
|
||
听
2
听
| Exhibit 31.1 |
Certification
by Phillip Frost, MD, Chief Executive Officer, pursuant to Rule 13a-14(a)
or 15d-14(a) of the Securities and Exchange Act of 1934 as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for the
quarterly period ended June 30, 2007.
|
听
| Exhibit 31.2 |
Certification
by Rao Uppaluri, Chief Financial Officer, pursuant to Rule 13a-14(a)
or
15d-14(a) of the Securities and Exchange Act of 1934 as adopted
pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002 for the quarterly
period
ended June 30, 2007.
|
听
| Exhibit 32.1 |
Certification
by Phillip Frost, MD, Chief Executive Officer, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act
of 2002 for the quarterly period ended June 30, 2007.
|
听
| Exhibit 32.2 |
Certification
by Rao Uppaluri, Chief Financial Officer, pursuant to 18 U.S.C.
Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
for the quarterly period ended June 30,
2007.
|
听
3